Farzaneh Atashrazm
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Plasticity in EGFR-mutant NSCLC: SCLC transformation and subsequent re-emergence: case report.
Journal: Frontiers in oncology
Published: June 07, 2026
Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review.
Journal: Translational lung cancer research
Published: April 15, 2025
Lung cancer biobanking in Australia: challenges and future directions.
Journal: The Medical journal of Australia
Published: January 16, 2025
LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 24, 2018
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease.
Journal: Scientific reports
Published: August 06, 2018
Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice.
Journal: Neurobiology of disease
Published: July 06, 2018
LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives.
Journal: Clinical pharmacology : advances and applications
Published: November 02, 2016
Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
Journal: Oncotarget
Published: March 17, 2016
Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.
Journal: Journal of cellular physiology
Published: June 12, 2015
Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.
Journal: Marine drugs
Published: February 24, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026